Lilly announces $2.5bn high-tech manufacturing site in Alzey, Germany
Eli Lilly and Company (NYSE: LLY) unveiled its plan to build a $2.5 billion state-of-the-art manufacturing site in Alzey, Rhineland-Palatinate, Germany. This new facility, earmarked for parenteral (injectable) product and device manufacturing, will significantly bolster Lilly’s capacity to meet rising global demand for its diabetes and obesity medications. A Commitment to Global Health and Innovation […]